Opeyemi A. Olabisi, MD, PhD, and Tomokazu Souma, MD, PhD, have been elected to the American Society for Clinical Investigation, one of the nation's oldest medical honor societies. Both are associate professors of medicine in the Division of Nephrology.

Autologous CAR T cell therapy, which involves taking immune system cells from a patient, altering them to improve their ability to fight disease, and then infusing them back into the patient, has b

Heather Hamby, MPH, has been named the new executive vice dean for administration for Duke University School of Medicine, effective June 1, 2025.  

John Karickhoff recently gave $1 million to launch the Duke Ocular Innovation Hub. The hub will serve both as an engine to drive innovation and a repository for innovations developed at Duke Eye Center.

Three Duke University School of Medicine faculty members have been honored for their contributions to biomedical science with awards from the American Society for Clinical Investigation (ASCI), one of the nation’s oldest medical honor societies.

Using enhanced imaging technology, Duke researchers identified a previously unknown part of photoreceptor cells in the retina.

Duke University School of Medicine researchers reveal how fungi can be both a species-threatening force and a vital part of our ecosystem. From recycling nutrients and trapping carbon to making bread rise and producing antibiotics, fungi are indispensable.

Cameron McIntyre, a professor of biomedical engineering and a professor in neurosurgery, has developed research that enables doctors to visualize a patient's brain in three dimensions. By using holograms, neurosurgeons can perform complex surgeries to alleviate tremors associated with Parkinson's disease and epilepsy.

Duke University School of Medicine has joined the Global Virus Network (GVN) as one of its newest Centers of Excellence. Collaborating entities include the Duke Research and Discovery @RTP, the Duke Global Health Institute and the Duke Human Vaccine Institute (DHVI).

A new blood test can help predict the survival of patients with advanced prostate cancer, according to research published by Duke Cancer Institute members Andrew Armstrong, MD, and Susan Halabi, PhD